News for Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)

Published at

Jul 6, 2023 11:01 PM

by prnewswire.com

mixed

mixed

Esophageal Cancer Market to Proliferate at a CAGR of 5.9% During the Study Period (2019-2032), Estimates DelveInsight

/PRNewswire/ -- DelveInsight's Esophageal Cancer Market Insights report includes a comprehensive understanding of current treatment practices, esophageal...

SGEN BCEL 0A8R.L XNCR LLY.MX LLY.DE LLY.BA LLY LILY34.SA INCY I1NC34.SA 0Q1G.L 0J9P.L 002317.SZ LPTX CSPHF CRIS ATNX 600276.SS

Read more →
Published at

Oct 6, 2021 2:00 AM

by globenewswire.com

mixed

mixed

Extremely Robust Esophageal Cancer Pipeline Expected to Change the Pace of Cancer Treatment as Many Critical Pharma Companies are Proactively Participating in Developing Novel Therapies Estimates Delv

There is increased research and development for new drug discovery for the treatment of Esophageal Cancer. There are more than 80+ companies that are...

RCUS INCY IMUN I1NC34.SA HGEN FATE BLCM ATRA ADAP 0J9P.L 0HIY.L 002317.SZ SGEN LLY.MX LLY.DE LLY.BA LLY LILY34.SA AMGN.MX AMGN.BA AMGN AMG.DE ABBV34.SA ABBV.MX ABBV.BA ABBV 4AB.DE 0Q1G.L 0A8R.L

Read more →